US 12,138,471 B2
Methods for treating disorders and for stimulating stem cells by administering light therapy
Peter Robert Brawn, Vancouver (CA); and Ke Shyang See, George Town (MY)
Assigned to Biolux Group SA, Geneva (CH)
Appl. No. 17/309,538
Filed by Biolux Group SA, Anieres (CH)
PCT Filed Dec. 13, 2019, PCT No. PCT/CA2019/051810
§ 371(c)(1), (2) Date Jun. 4, 2021,
PCT Pub. No. WO2020/118449, PCT Pub. Date Jun. 18, 2020.
Claims priority of provisional application 62/779,615, filed on Dec. 14, 2018.
Prior Publication US 2022/0118274 A1, Apr. 21, 2022
Int. Cl. A61N 5/06 (2006.01)
CPC A61N 5/0613 (2013.01) [A61N 5/0603 (2013.01); A61N 5/0616 (2013.01); A61N 5/0618 (2013.01); A61N 2005/0606 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0663 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A method for preferentially activating oral stem cells, comprising:
positioning an intra-oral device within the oral cavity of a subject; and
intra-orally administering a first effective amount of light at a first wavelength to a first selected region of the oral cavity of the subject; and
intra-orally administering a second effective amount of light at a second wavelength to a second selected region of the oral cavity in need thereof such that a directional migration of the oral stem cells into blood vessels is enhanced and the oral cavity is differentially treated, wherein the first wavelength is different from the second wavelength and the first selected region is different from the second selected region of the oral cavity.